PT Metro Healthcare Indonesia Tbk (IDX:CARE)
Indonesia
· Delayed Price · Currency is IDR 212.00
+2.00 (0.95%)
Mar 27, 2025, 4:05 PM WIB
IDX:CARE Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 319,022 | 242,681 | 260,426 | 290,934 | 216,296 | Upgrade
|
| Revenue Growth (YoY) | 31.46% | -6.81% | -10.49% | 34.51% | 40.38% | Upgrade
|
| Cost of Revenue | 214,435 | 154,716 | 166,533 | 146,481 | 114,639 | Upgrade
|
| Gross Profit | 104,588 | 87,965 | 93,893 | 144,454 | 101,657 | Upgrade
|
| Selling, General & Admin | 134,515 | 115,939 | 145,618 | 120,302 | 111,011 | Upgrade
|
| Other Operating Expenses | - | 7,782 | 8,663 | 8,748 | 3,569 | Upgrade
|
| Operating Expenses | 134,515 | 124,104 | 154,484 | 130,356 | 117,174 | Upgrade
|
| Operating Income | -29,928 | -36,139 | -60,591 | 14,098 | -15,517 | Upgrade
|
| Interest Expense | -77,315 | -75,775 | -89,333 | -25,432 | -11,306 | Upgrade
|
| Interest & Investment Income | - | 6,623 | 31,785 | 15,782 | 40,428 | Upgrade
|
| Other Non Operating Income (Expenses) | 31,479 | -904.24 | -844.92 | -694.16 | 187.68 | Upgrade
|
| EBT Excluding Unusual Items | -75,764 | -106,195 | -118,984 | 3,754 | 13,793 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 72 | 25,668 | 76.36 | - | Upgrade
|
| Other Unusual Items | - | - | - | 2,676 | - | Upgrade
|
| Pretax Income | -75,764 | -106,123 | -93,316 | 6,507 | 13,793 | Upgrade
|
| Income Tax Expense | 4,153 | 4,566 | 288.46 | 332.91 | -375.14 | Upgrade
|
| Earnings From Continuing Operations | -79,917 | -110,689 | -93,604 | 6,174 | 14,168 | Upgrade
|
| Minority Interest in Earnings | -391.96 | -230.93 | 60.53 | -74.43 | 144.89 | Upgrade
|
| Net Income | -80,309 | -110,920 | -93,544 | 6,099 | 14,313 | Upgrade
|
| Net Income to Common | -80,309 | -110,920 | -93,544 | 6,099 | 14,313 | Upgrade
|
| Net Income Growth | - | - | - | -57.39% | - | Upgrade
|
| Shares Outstanding (Basic) | 33,186 | 33,250 | 33,250 | 33,250 | 28,250 | Upgrade
|
| Shares Outstanding (Diluted) | 33,186 | 33,250 | 33,250 | 33,250 | 28,250 | Upgrade
|
| Shares Change (YoY) | -0.19% | - | - | 17.70% | 264.44% | Upgrade
|
| EPS (Basic) | -2.42 | -3.34 | -2.81 | 0.18 | 0.51 | Upgrade
|
| EPS (Diluted) | -2.42 | -3.34 | -2.81 | 0.18 | 0.51 | Upgrade
|
| EPS Growth | - | - | - | -63.80% | - | Upgrade
|
| Free Cash Flow | -339,941 | -95,595 | -339,291 | -263,276 | -471,965 | Upgrade
|
| Free Cash Flow Per Share | -10.24 | -2.88 | -10.20 | -7.92 | -16.71 | Upgrade
|
| Gross Margin | 32.78% | 36.25% | 36.05% | 49.65% | 47.00% | Upgrade
|
| Operating Margin | -9.38% | -14.89% | -23.27% | 4.85% | -7.17% | Upgrade
|
| Profit Margin | -25.17% | -45.71% | -35.92% | 2.10% | 6.62% | Upgrade
|
| Free Cash Flow Margin | -106.56% | -39.39% | -130.28% | -90.49% | -218.20% | Upgrade
|
| EBITDA | -5,865 | -14,554 | -37,714 | 31,395 | -3,398 | Upgrade
|
| EBITDA Margin | -1.84% | -6.00% | -14.48% | 10.79% | -1.57% | Upgrade
|
| D&A For EBITDA | 24,062 | 21,585 | 22,878 | 17,297 | 12,119 | Upgrade
|
| EBIT | -29,928 | -36,139 | -60,591 | 14,098 | -15,517 | Upgrade
|
| EBIT Margin | -9.38% | -14.89% | -23.27% | 4.85% | -7.17% | Upgrade
|
| Effective Tax Rate | - | - | - | 5.12% | - | Upgrade
|
| Advertising Expenses | - | 332.36 | 621.1 | 204.18 | - | Upgrade
|
Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.